Assessment of the effect of oxycodone on brain parenchymal elasticity in children with congenital heart disease based on shear wave elastography

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500112806

Enrollment

Unknown

Registered

2025-11-19

Start date

2025-12-01

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital heart disease

Interventions

Group S:Induction opioid: sufentanil 1 µg/kg

Group O:Induction opioid: oxycodone 1 mg/kg

Eligibility

Sex/Gender

All

Age

No minimum to 0.5 Years

Inclusion criteria

Inclusion criteria: 1. Age: 0–6 months; 2. Gender: unrestricted; 3. Paediatric patients requiring elective corrective surgery for congenital heart disease; 4. American Society of Anaesthesiologists (ASA) physical status classification: ASA II–IV; 5. Guardian voluntarily signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Severe organic pathology present preoperatively; 3. Vasoactive drugs administered preoperatively; 4. The child's guardian declines to participate in the study.

Design outcomes

Primary

Measure	Time frame
Brain parenchymal elasticity;Duration of mechanical ventilation;	—

Secondary

Measure	Time frame
Vital signs;Length of stay in ICU;	—

Countries

China

Contacts

Public ContactLiping Sun

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

suntangmama@163.com+86 135 0163 6482

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026